SXTC icon

China SXT Pharmaceuticals
SXTC

5 hedge funds and large institutions have $139K invested in China SXT Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
5
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$48K
2
+$24.2K
3
+$24K
4
Millennium Management
Millennium Management
New York
+$12K
5
UBS Group
UBS Group
Switzerland
+$1.51K

Top Sellers

1
-$17K
2
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$48K
2
$37K
3
$24.2K
4
$24K
5
$5.73K
6
–
7
–